Abstract
In our continuous efforts to identify and develop novel targeted cancer treatments, a new morpholino-thiazole scaffold active against PI3Kβ has been identified. This Letter reports the optimization of this compound class to develop PI3Kβ isoform-selective inhibitors with suitable pharmacological properties.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1506-1510 |
| Number of pages | 5 |
| Journal | Bioorganic and Medicinal Chemistry Letters |
| Volume | 24 |
| Issue number | 6 |
| DOIs | |
| State | Published - Mar 15 2014 |
| Externally published | Yes |
Keywords
- pAKT
- PI3Kβ
- PTEN
- Thiazole
ASJC Scopus subject areas
- Biochemistry
- Clinical Biochemistry
- Molecular Biology
- Molecular Medicine
- Organic Chemistry
- Drug Discovery
- Pharmaceutical Science
Fingerprint
Dive into the research topics of 'Preparation and optimization of new 4-(2-(indolin-1-yl)-2-oxoethyl)-2- morpholinothiazole-5-carboxylic acid and amide derivatives as potent and selective PI3Kβ inhibitors'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS